In Memoriam: James M. Slater, pioneer of proton therapy, transformed cancer treatment

January 02, 2019

James M. Slater, MD, whose determination to improve the quality of life for patients undergoing cancer treatment inspired him to use proton therapy for patient care and to champion and oversee creation of the world's first hospital-based proton treatment center at Loma Linda University Health, dies Dec 26. He was 89.

Provision Nashville’s First Patient Celebrates Treatment Completion with Victory Bell Ceremony

November 14, 2018

Mr. James Williams celebrated the completion of his treatment with a bell-ringing ceremony on November 14, 2018 at Provision CARES Proton Therapy Nashville.

Annual Survey Shows Surge in Cancer Patients Treated With Proton Therapy & in Number of Indications

March 26, 2018

Over the past four years, the number of proton therapy centers has doubled and a growing number of patients are being treated for an increasing variety of cancers. 

Protons with a purpose

March 20, 2018

As many as 115 patients treated each day. Upwards of 5,000 people who have received life-saving care since 2010. As impressive as these numbers are, the outcomes at the Roberts Proton Therapy Center are even more so. 

How proton therapy attacks cancer

March 06, 2018

These once-exotic weapons in the cancer-fighting arsenal are getting faster, cheaper and more common.

First proton therapy center in Middle TN to open in Franklin

March 01, 2018

Middle Tennessee residents will soon have a new option for an innovative cancer treatment. 

Children in developing countries can benefit from proton therapy

February 22, 2018

Children with cancer are arguably set to benefit most from proton therapy as the number of clinics worldwide continues to grow. Steep dose gradients enable superior sparing of healthy tissue compared to photons, reducing the lifetime risk of radiation-induced cancer and increasing survival. 

Provision Healthcare successfully treats first patients with new proton therapy system

February 17, 2018

Provision Healthcare has successfully treated its first patients using Blount County-based ProNova Solutions' newly developed SC360 proton therapy system at the Provision CARES Cancer Center in Knoxville. 

American Society for Radiation Oncology updates insurance coverage recommendations for proton therapy

July 13, 2017

Proton beam therapy model policy recommends expanded access to advanced radiation therapy treatment for cancer patients

Proton therapy shows promise for recurrent lung cancer

March 20, 2017

Intensity-modulated proton therapy conferred durable control with minimal toxicity among patients with recurrent thoracic cancer, according to results of a retrospective study presented at the Multidisciplinary Thoracic Cancers Symposium.

Proton therapy offers new treatment possibility for recurrent lung cancer

March 17, 2017

Advanced form of image-guided radiation therapy is an option for patients who previously had none

Proton therapy represents a niche, but growing market.

March 08, 2017

The global particle therapy device market (mainly proton therapy devices) reached $750 million in 2015. The market growth has accelerated during the last five years, showing an average annual growth rate of 19 percent from 2010 to 2015. For the first time, the proton therapy world market is anticipated to reach over $1 billion in 2018, one year sooner than previously estimated. It is projected to reach between $3.5 billion and $6.6 billion by 2030, with 1,200 to 1,800 particle therapy treatment rooms open to patients worldwide. 

Pencil beam scanning: The proton therapy innovation of the future.

March 05, 2017

As our ability to treat cancer improves, patients are living longer. 

Orlando Health and Mevion Offer Advanced Diagnostic Image Guidance for Proton Therapy

January 25, 2017

Mevion integrates in-room CT images to its Verity Patient Positioning System for the MEVION S250 at UF Health Cancer Center - Orlando Health.

Particle therapy offers safer re-irradiation

October 26, 2016

Head-and-neck squamous cell carcinoma (HNSCC) is a particularly difficult cancer to cure, with a post-treatment recurrence risk of up to 30% and a 12–13% five-year incidence of second new tumors. Patients treated for recurrence with surgical resection plus re-irradiation can experience long-term disease control, but rates of severe toxicity are high. Reducing the risk of radiation-induced complications is an essential goal.

How Is Proton Therapy Research Benefiting Pediatric Cancer and Multimodal Treatments? Q&A with Dr. Perentesis

October 19, 2016

In this Q&A, Dr. Perentesis shares his thoughts on some of the benefits of proton therapy research including reducing side effects and secondary cancers, as well as improving long-term outcomes

U.S. proton therapy market to reach $1 billion by 2022 with 38 facilities

October 14, 2016

According to the report, by 2022, the US will have 38 proton therapy centers. Consequently, the market will attain revenue of around US$ 1 Billion by 2022, growing at a CAGR of over 16% during the forecast period (2015-2022). 

Proton Therapy World Market is expanding faster

October 07, 2016

The global particle therapy devices market (mainly proton therapy devices) reached US$ 750 million in 2015. Market growth has accelerated during the last five years, showing an average annual growth rate of 19% from 2010 to 2015. For the first time, the proton therapy world market is anticipated to reach over US$ 1 billion in 2018, one year sooner than previously estimated. It is projected to reach between US$ 3.5 and 6.6 billion by 2030, with 1,200 to 1,800 particle therapy treatment rooms open to patients worldwide.

Mevion Defines Adaptive IMPT with HYPERSCAN with Adaptive Aperture

September 22, 2016

Mevion Showcases Advancements for Faster, Sharper and Robust Pencil Beam Scanning Technology at ASTRO 2016. 

Utilizing Multi-Field Optimization with IMPT for Head and Neck Cancer Treatment

September 07, 2016

Head and neck cancers can be challenging to treat as they are often adjacent to multiple critical structures, such as the optic nerves or the brain stem. At Scripps, we are successfully treating these complex cancers using multi-field optimization intensity-modulated proton therapy (MFO-IMPT) and CBCT. 

The world's first single-room proton therapy facility: Two-year experience.

July 09, 2016

This is a review of a 2-year experience with the first single-gantry proton therapy (PT) system.

Adaptive Radiotherapy Optimizes Proton Therapy Treatments

June 29, 2016

Adaptive radiotherapy has been considered a necessary quality assurance practice for high-precision patient treatment, and we are at the very beginning of making this a clinical reality. In-room CBCT is a powerful tool..

Results reported at first all pencil-beam proton center in US

May 20, 2016

America's first and only proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care just more than a year ago.

As proton therapy becomes cheaper, more hospitals look to add centers

April 25, 2016

Planning for smaller facilities with smaller footprints has reduced the amount of up-front costs for the cancer treatment centers, experts say.

Brain tumour boy Ashya King is free of cancer after proton therapy, parents say

March 03, 2016

The parents of five-year-old Ashya King, who were jailed after taking him abroad for brain tumor treatment, say their son is now free of cancer.

Mevion S250 proton therapy accelerator arrives in Georgetown

February 19, 2016

The MEVION S250 from Mevion Medical Systems has seen significant adoption and investment over the last few years. 

Please reload

 © 2021 by Integrated Proton Solutions, LLC    I    All Rights Reserved.

This site was designed with the
website builder. Create your website today.
Start Now